Yu Lan, Yu Shujie, Wang Feng, Zhou Xiaofang, Yang Feiman, Cao Dairong, Xing Zhen
Department of Radiology, The First Affiliated Hospital, Fujian Medical University, 20 Cha-Zhong Road, Fuzhou, Fujian, 350005, P.R. China.
Department of Radiology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350212, China.
BMC Med Imaging. 2025 Aug 25;25(1):345. doi: 10.1186/s12880-025-01886-9.
The differential diagnosis of primary central nervous system lymphoma (PCNSL) and atypical glioblastoma (aGBM) exhibiting homogeneous enhancement and negligible necrosis poses a significant challenge for conventional MRI. The study aims to investigate diffusion-weighted imaging (DWI), dynamic contrast-enhanced (DCE) MRI, and contrast agent (CA) preload dynamic susceptibility contrast perfusion-weighted imaging (DSC-PWI) to differentiate aGBM and PCNSL.
This retrospective study analyzed 27 patients with aGBM (solid enhancement without visible necrosis) and 105 patients with PCNSL, all undergoing preoperative DWI, DCE-MRI, and CA preload DSC-PWI. The relative apparent diffusion coefficient (rADC) and relative cerebral blood volume (rCBV) were obtained from DWI and DSC-PWI. The pharmacokinetic parameters (Ktrans, Ve, Kep, and iAUC) were acquired using DCE-MRI. The independent-samples t-test and Mann-Whitney U test were utilized to compare parameters. A binary logistic regression analysis was performed to assess the combined effect of various parameters. Before regression analysis, collinearity analysis of parameters was performed. The diagnostic capability of each parameter and their combination were evaluated by receiver operating characteristic (ROC) with area under the curve (AUC) and compared with DeLong test.
In comparison to aGBM, the Ktrans, Ve, and iAUC were significantly elevated in PCNSL, whereas the rCBV and rADC were significantly lower (p < 0.05 for all comparisons). Meanwhile, these parameters allowed excellent diagnostic performance (AUC = 0.817 [rCBV], 0.751 [rADC], 0.808 [Ktrans], 0.765 [Ve], and 0.801 [iAUC]; DeLong test, p > 0.05 for all comparisons). Notably, the combination of all these parameters significantly increased the probability of distinguishing aGBM from PCNSL (AUC = 0.966).
DWI, DCE-MRI, and CA preload DSC-PWI can effectively differentiate aGBM from PCNSL, and the combination of all three techniques significantly enhances the discriminatory efficacy.
原发性中枢神经系统淋巴瘤(PCNSL)与表现为均匀强化且坏死可忽略不计的非典型胶质母细胞瘤(aGBM)的鉴别诊断对传统MRI构成重大挑战。本研究旨在探讨扩散加权成像(DWI)、动态对比增强(DCE)MRI和对比剂(CA)预负荷动态磁敏感对比灌注加权成像(DSC-PWI)以区分aGBM和PCNSL。
本回顾性研究分析了27例aGBM患者(实性强化且无明显坏死)和105例PCNSL患者,所有患者均接受术前DWI、DCE-MRI和CA预负荷DSC-PWI检查。从DWI和DSC-PWI中获取相对表观扩散系数(rADC)和相对脑血容量(rCBV)。使用DCE-MRI获取药代动力学参数(Ktrans、Ve、Kep和iAUC)。采用独立样本t检验和Mann-Whitney U检验比较参数。进行二元逻辑回归分析以评估各种参数的联合效应。在回归分析之前,对参数进行共线性分析。通过曲线下面积(AUC)的受试者工作特征(ROC)评估每个参数及其组合的诊断能力,并与DeLong检验进行比较。
与aGBM相比,PCNSL中的Ktrans、Ve和iAUC显著升高,而rCBV和rADC显著降低(所有比较p < 0.05)。同时,这些参数具有出色的诊断性能(AUC = 0.817 [rCBV],0.751 [rADC],0.808 [Ktrans],0.765 [Ve],0.801 [iAUC];DeLong检验,所有比较p > 0.05)。值得注意的是,所有这些参数的组合显著提高了区分aGBM和PCNSL的概率(AUC = 0.966)。
DWI、DCE-MRI和CA预负荷DSC-PWI能够有效区分aGBM和PCNSL,并且这三种技术的组合显著提高了鉴别效能。